Affiliation:
1. Departamento de Farmacologia Bäsica e Clinica, Institute de Ciências Biomédicas, Centro de Ciências da Saude, Universidade Federal do Rio de Janeiro, Rio de Janeiro
2. Departamento do Tecnologia Farmacêulica, Faculdade de Farmäcia, Universidade Federal do Rio de Janeiro, 21944.390 Rio de Janeiro, Brasil
Abstract
Abstract
A series of 5-pyrazolylhydrazone derivatives was designed to be mixed hybrid isosteres of both BW755C and CBS-1108, which belong to the class of dual cyclo-oxygenase and 5-lipoxygenase inhibitors. Some derivatives of this series inhibit the in-vitro platelet aggregation of citrated platelet-rich rabbit plasma induced by ADP (5 μm), collagen (5 μg mL−1) and arachidonic acid (100 μm). The structure-activity relationships of this class of compounds were determined from these results. When ADP is used as the aggregation inducer, the presence of free oxygenated substituents at the p-position in the phenyl subunit of the hydrazone moiety favours inhibitory activity; p-methoxyformylbenzene-5-(1-phenyl-3-methyl-4-nitropyrazolyl)hydrazone (100 μm), which has a methoxy group at this position was the most active with 62·8% inhibition of aggregation. In contrast, substitution in the aryl ring does not affect the aggregation induced by collagen, whereas the non-substituted compound, formylbenzene-5-(1-phenyl-3-methyl-4-nitropyrazolyl)hydrazone, showed similar activity to those of substituted derivatives. In the arachidonic acid assays, the presence of an aryl ring linked to the hydrazone moiety, with an adequate electronic density at the ring due to the nature of its substitutents, is an important structural requirement for inhibitory activity.
Publisher
Oxford University Press (OUP)
Subject
Pharmaceutical Science,Pharmacology
Reference20 articles.
1. Multiple effects of a new anti-inflammatory agent, timegadine, on arachidonic acid release and metabolism in neutrophils and platelets;Ahnfelt-Ronne;Biochem. Pharmacol.,1982
2. The aggregation of blood platelets;Born;J. Physiol.,1963
3. Aggregation of rabbit platelets by platelet-activating factor is independent of the release reaction and the arachidonate pathway and inhibited by membrane-active drugs;Cazenave;Lab. Invest.,1979
4. L'Agrégation plaquettaire: outil d'investigation clinique et d'étude pharmacologique—Méthodologie;Cazenave;Ann. Biol. Clin.,1983
5. Interrelations of platelet aggregation and secretion;Charo;J. Clin. Invest.,1977
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献